18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)-Reference-Cited by-同舟云学术

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Published:2017-11-22 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Martínez Gabriel¹²³,Vernooij Robin WM¹,Fuentes Padilla Paulina¹²,Zamora Javier⁴,Flicker Leon⁵,Bonfill Cosp Xavier⁶⁷

Affiliation:

1. Iberoamerican Cochrane Centre; C/ Sant Antoni Maria Claret 167 Pavelló 18 Planta 0 Barcelona Barcelona Spain 08025

2. Universidad de Antofagasta; Faculty of Medicine and Dentistry; Antofagasta Chile

3. Institut Català de Neurociències Aplicades; Alzheimer Research Center and Memory Clinic of Fundació ACE; Barcelona Spain

4. Ramon y Cajal Institute for Health Research (IRYCIS), CIBER Epidemiology and Public Health (CIBERESP), Madrid (Spain) and Women's Health Research Unit, Centre for Primary Care and Public Health, Queen Mary University of London; Clinical Biostatistics Unit; London Madrid UK

5. University of Western Australia; Western Australian Centre for Health & Ageing - WACHA; Crawley Perth Western Australia Australia 6014

6. CIBER Epidemiología y Salud Pública (CIBERESP); Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 167 Pavilion 18 Barcelona Catalunya Spain 08025

7. Universitat Autònoma de Barcelona; Sant Antoni Maria Claret, 167 Pavilion 18 (D-13) Barcelona Catalunya Spain 08025

Publisher

Wiley

Subject

Pharmacology (medical)

Reference109 articles.

1. EUCTR2009-010227-62-GB A principal open-label study to assess the prognostic usefulness of flutemetamol (F18) injection for identifying subjects with amnestic mild cognitive impairment who will convert to probable Alzheimer’s disease apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-010227-62-GB

2. NCT01028053 Assess the prognostic usefulness of flutemetamol (18F) injection for identifying subjects with amnestic mild cognitive impairment who will convert to clinically probable Alzheimer's disease www.clinicaltrials.gov/show/NCT01028053

3. Combination of biomarkers: PET [18F] flutemetamol imaging and structural MRI in dementia and mild cognitive impairment;Thurfjell;Neuro-degenerative Diseases,2012

4. Anxiety is associated with brain amyloidosis in cognitively normal and mild cognitive impairment subjects: a [18f] flutemetamol PET study;Goukasian;Alzheimer's & Dementia,2015

5. Rowe CC Dore V Bourgeat P Brown BM Thurfjell L Macaulay L Abeta accumulation in non-demented individuals: a longitudinal F-18-flutemetamol study Alzheimer's & Dementia 2015 125

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scottish Intercollegiate Guidelines Network Guidance on Dementia: The Investigation of Suspected Dementia (SIGN 168) with Focus on Biomarkers—Executive Summary;Thrombosis and Haemostasis;2024-05-24

2. Symptoms and Diagnosis of Dementia;Nutritional Neurosciences;2024

3. Neurodegenerative und Demenzielle Erkrankungen;PET/CT-Atlas;2024

4. Biological Diagnosis of Alzheimer’s Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?;International Journal of Molecular Sciences;2023-12-16

5. Predicting cognitive decline in older people by structural and molecular imaging;Current Opinion in Neurology;2023-06-19